oxazoles has been researched along with Diabetic Glomerulosclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Adeghate, E; Csekő, K; Dányádi, B; Deres, L; Ferdinandy, P; Gábriel, R; Halmosi, R; Helyes, Z; Horváth, ÁI; Kőszegi, T; Kovács-Valasek, A; Mátyus, P; Pintér, E; Sághy, É; Szabadfi, K; Tékus, V; Varga, ZV | 1 |
| Hanefeld, M; Herz, M; Lincoff, AM; Malmberg, K; Meyer-Reigner, S; Mudie, N; Ruilope, L; Viberti, G; Wieczorek Kirk, D | 1 |
| Atzpodien, EA; Bénardeau, A; Funk, JM; Meyer, M; Mizrahi, J; Sebokova, E; Uhles, S; Verry, P; Winter, M; Wright, MB | 1 |
1 trial(s) available for oxazoles and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Dyslipidemias; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Kidney; Male; Middle Aged; Oxazoles; Pioglitazone; PPAR alpha; PPAR gamma; Renal Insufficiency, Chronic; Therapeutic Equivalency; Thiazolidinediones; Thiophenes | 2014 |
2 other study(ies) available for oxazoles and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Protective effects of the novel amine-oxidase inhibitor multi-target drug SZV 1287 on streptozotocin-induced beta cell damage and diabetic complications in rats.
Topics: Amine Oxidase (Copper-Containing); Analgesics; Animals; Cell Adhesion Molecules; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diabetic Retinopathy; Humans; Hydrazines; Insulin; Insulin-Secreting Cells; Male; Monoamine Oxidase Inhibitors; Oxazoles; Oximes; Rats; Rats, Sprague-Dawley; Streptozocin | 2021 |
Effects of the dual PPAR-α/γ agonist aleglitazar on glycaemic control and organ protection in the Zucker diabetic fatty rat.
Topics: Animals; Blood Glucose; Cataract; Diabetic Nephropathies; Glucose Tolerance Test; Glycated Hemoglobin; Hypoglycemic Agents; Immunohistochemistry; Insulin; Islets of Langerhans; Male; Oxazoles; PPAR alpha; PPAR gamma; Rats; Rats, Zucker; Thiophenes | 2013 |